These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6294139)

  • 21. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein.
    Ecke S; Geiger M; Resch I; Jerabek I; Sting L; Maier M; Binder BR
    J Biol Chem; 1992 Apr; 267(10):7048-52. PubMed ID: 1313031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High affinity binding sites for activated protein C and protein C on cultured human umbilical vein endothelial cells. Independent of protein S and distinct from known ligands.
    Bangalore N; Drohan WN; Orthner CL
    Thromb Haemost; 1994 Sep; 72(3):465-74. PubMed ID: 7855799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo inactivation of factor V by a vitamin K-dependent factor. Study of an individual with combined factor V/VIII deficiency.
    Bauer F; Schapira M; Mannucci PM; Bouvier CA
    Thromb Res; 1983 Feb; 29(4):453-7. PubMed ID: 6687958
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.
    Petäjä J; Fernández JA; Gruber A; Griffin JH
    J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does activated protein C-resistant factor V contribute to thrombin generation in hemophilic plasma?
    Bos MH; Meijerman DW; van der Zwaan C; Mertens K
    J Thromb Haemost; 2005 Mar; 3(3):522-30. PubMed ID: 15748243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor V enhances the cofactor function of protein S in the APC-mediated inactivation of factor VIII: influence of the factor VR506Q mutation.
    Váradi K; Rosing J; Tans G; Pabinger I; Keil B; Schwarz HP
    Thromb Haemost; 1996 Aug; 76(2):208-14. PubMed ID: 8865533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bovine plasma protein C inhibitor with structural and functional homologous properties to human plasma protein C inhibitor.
    Suzuki K; Kusumoto H; Nishioka J; Komiyama Y
    J Biochem; 1990 Mar; 107(3):381-8. PubMed ID: 2160449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of plasma proteinase inhibitors to the regulation of activated protein C in plasma.
    Marlar RA; Kressin DC; Madden RM
    Thromb Haemost; 1993 Jan; 69(1):16-20. PubMed ID: 8383358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The defect in hemophilic and von Willebrand's disease plasmas studied by a recombination technique.
    Cooper HA; Wagner RH
    J Clin Invest; 1974 Nov; 54(5):1093-9. PubMed ID: 4213756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of monoclonal antibodies that inhibit the function of protein C inhibitor. Evidence for heparin-independent inhibition of activated protein C in plasma.
    Meijers JC; Vlooswijk RA; Kanters DH; Hessing M; Bouma BN
    Blood; 1988 Oct; 72(4):1401-3. PubMed ID: 2844328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physiologic inhibition of human activated protein C by alpha 1-antitrypsin.
    Heeb MJ; Griffin JH
    J Biol Chem; 1988 Aug; 263(24):11613-6. PubMed ID: 3261294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species specificity of anticoagulant activity of activated human protein C: involvement of factor V as well as protein S.
    Katsuura Y; Mochizuki T; Tamura M; Hoshide S; Kiyoki M; Nakagaki T; Miyamoto S
    Thromb Res; 1996 Apr; 82(2):147-57. PubMed ID: 9163068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of inhibition of activated protein C by protein C inhibitor.
    Suzuki K; Nishioka J; Kusumoto H; Hashimoto S
    J Biochem; 1984 Jan; 95(1):187-95. PubMed ID: 6323392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological studies in combined factor V and factor VIII deficiency.
    Giddings JC; Seligsohn U; Bloom AL
    Br J Haematol; 1977 Oct; 37(2):257-64. PubMed ID: 603759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A second plasma inhibitor of activated protein C: alpha 1-antitrypsin.
    van der Meer FJ; van Tilburg NH; van Wijngaarden A; van der Linden IK; Briët E; Bertina RM
    Thromb Haemost; 1989 Sep; 62(2):756-62. PubMed ID: 2554521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma1.
    Brummel-Ziedins KE; Whelihan MF; Rivard GE; Butenas S
    J Thromb Haemost; 2011 Nov; 9(11):2262-7. PubMed ID: 21920012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's.
    España F; Griffin JH
    Thromb Res; 1989 Sep; 55(6):671-82. PubMed ID: 2551066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects.
    Okajima K; Koga S; Kaji M; Inoue M; Nakagaki T; Funatsu A; Okabe H; Takatsuki K; Aoki N
    Thromb Haemost; 1990 Feb; 63(1):48-53. PubMed ID: 2140205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter evaluation of a kit for activated protein C resistance on various coagulation instruments using plasmas from healthy individuals. The APC Resistance Study Group.
    Rosén S; Johansson K; Lindberg K; Dahlbäck B
    Thromb Haemost; 1994 Aug; 72(2):255-60. PubMed ID: 7831662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolysis of protein C in pooled normal plasma and purified protein C by activated protein C (APC).
    Hassouna H; Quinn C
    Biophys Chem; 2002 Feb; 95(2):109-24. PubMed ID: 11897150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.